Iontophoresis: An alternative to the use of carriers in cutaneous drug delivery

Advanced Drug Delivery Reviews

Volumn 18, Issue 3, 1996, Pages 379-394

  Singh, Parminder ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Factor; Iontophoresis; Peptide; Protein; Transdermal applications

Indexed keywords

COMPOSITION EFFECTS; DRUG INFUSION; DRUG INTERACTIONS; PHYSIOLOGY; PROTEINS; SKIN;

CUTANEOUS DRUG DELIVERY; IONTOPHORESIS; PARENTERAL THERAPY; PEPTIDES; STRATUM CORNEUM; TRANSDERMAL APPLICATIONS;

CONTROLLED DRUG DELIVERY;

ACICLOVIR; ADRENALIN; ARBUTAMINE; ARGIPRESSIN; BRETYLIUM; CISPLATIN; GONADORELIN; GROWTH HORMONE RELEASING FACTOR; HISTAMINE; HUMAN INSULIN; IDOXURIDINE; INDOMETACIN; INSULIN; LEUPRORELIN; LIDOCAINE; METHYLENE BLUE; METOPROLOL; OXYCODONE; PEPTIDE; POTASSIUM IODIDE; PROPRANOLOL; PROTEIN; SALICYLIC ACID; UNINDEXED DRUG; VASOPRESSIN; VERAPAMIL; VIDARABINE PHOSPHATE; VINBLASTINE;

ANESTHESIA; ANIMAL MODEL; CLINICAL TRIAL; CYSTIC FIBROSIS; DIFFUSION; DRUG ADMINISTRATION; HUMAN; HYPERHIDROSIS; ION TRANSPORT; IONTOPHORESIS; NONHUMAN; PERMEABILITY BARRIER; PH; PRIORITY JOURNAL; REVIEW; SKIN; STRATUM CORNEUM; TECHNIQUE; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030574688     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(95)00082-I     Document Type: Review

References (123)

1. Sloan, J.B. and Soltani, K. (1986) Iontophoresis in dermatology. J. Am. Acad. Dermatol. 15, 671-684.
2. Bellantone, N.H., Rim, S., Francoeur, M.L. and Rasadi, B. (1986) Enhanced percutaneous absorption via iontophoresis I. Evaluation of an in vitro system and transport of model compounds. Int. J. Pharm. 30, 63-72.
3. Burnette, R.R. and Marreo, D. (1986) Comparison between the iontophoretic and passive transport of thyrotopin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75, 738-743.
4. Burnette, R.R. and Ongpipattanakul, B. (1987) Characterization of the permselectivc properties of excised human skin during iontophoresis. J. Pharm. Sci. 76, 765-773.
5. Phipps, J.B., Padmanabhan, R.V. and Lattin G.A. (1989) Iontophoretic delivery of model inorganic and drug ions. J. Pharm. Sci. 78, 365-369.
6. Banga, A. and Chein, Y.W. (1988) Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J. Control. Release 7, 1-24.
7. Gangarosa, L.P., Park, N.H., Wiggins, C.A. and Hill, J.M. (1980) Increased penetration of nonelectrolytes into hairless mouse skin during iontophoretic water transport (iontohydrokinesis). J. Pharmacol. Exp. Ther. 212, 377-381.
8. Schultz, S.G. (1980) Basic Principles of Membrane Transport. Cambridge University Press, New York, pp. 21-30.
9. Srinivasan, V., Higuchi, W.I. (1990) A model for iontophoresis incorporating the effect of convective solvent flow. Int. J. Pharm. 60, 133-139.
10. Pikal, M.J. (1990a) Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm. Res. 7, 118-126.
11. Roberts, M.S., Singh, J., Yoshida, N.H. and Currie, K.I. (1989) Iontophoretic transport of selected solutes through human epidermis. In: R.C. Scott, R.H. Guy and J. Hadgraft (Eds), Prediction of Percutaneous Absorption, IBC Technical Services, London, pp. 231-241.
12. Tyle, P. (1986) Iontophoretic devices for drug delivery. Pharm. Res. 3, 318-326.
13. Phoresor Iontophoretic Drug Delivery System: Package Insert, Motion Control Inc., Salt Lake City, UT.
14. Hölzle, E. and Ruzicka, T. (1986) Treatment of hyperhydrosis by a battery-operated iontophoretic device. Dermatologica 172, 41-47.
15. Hölzle, E. and Alberti, N. (1987) Long-term efficacy and side effects of tap water iontophoresis of palmoplantar hyperhydrosis-the usefulness of home therapy. Dermatologica 175, 126-135.
16. Grimnes, S. (1984) Pathways of ionic flow through human skin in vivo. Acta Derm. Venereol, (Stockh.) 64, 93-98.
17. Burnette, R.R. (1988) Iontophoresis. In J. Hadgraft and R.H. Guy (Eds), Transdermal Drug Delivery, Marcel Dekker, New York, 1988, Ch. 11.
18. Abramson, H.A. and Gorin, M.H. (1940) Skin reactions. IX. The electrophoretic demonstration of the patent pores of the living human skin; its relation to the charge of the skin. J. Phys. Chem. 44, 1094-1102.
19. Papa, C.M. and Kligman, A.M. (1966) Mechanism of eccrine anhydrosis. J. Invest. Dermatol. 47, 1-9.
20. Siddiqui, O., Sun, Y., Liu, J.C. and Chien, Y.W. (1987) Facilitated transport of insulin. J. Pharm. Sci. 76, 341-345.
21. Cullander, C. and Guy, R.H. (1991) Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode. J. Invest. Dermatol. 97, 55-64.
22. Monteiro-Riviere, N.A. (1991) Identification of the pathway of transdermal iontophoretic drug delivery: ultrastructural studies using mercuric chloride in vivo in pigs. Pharm. Res. 8, S-141.
23. Cullander, C. (1992) What are the pathways of iontophoretic current flow through mammalian skin? Adv. Drug Deliv. Rev. 9, 119-135.
24. Burnette, R.R. and Ongpipattanakul, B. (1987) Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J. Pharm. Sci. 77, 132-137.
25. Jung, G., Katz, H., Schmitt, H., Voges, K.P., Menestrina, G. and Boheim, G. (1983) Conformational requirements for the potential dependent pore formation of the peptide antibiotics alamethicin, suzukacillin and trichotoxin. In: Spach, G. (Ed.). Physical Chemistry of Transmembrane Ion Motion, Elsevier, New York.
26. Yoshida, N.H. and Roberts, M.S. (1992) Structure-transport relationships in transdermal iontophoresis. Adv. Drug Deliv. Rev. 9, 239-264.
27. Burnette, R.R. and Marreo, D. (1986) Comparison between the iontophoretic and passive transport of thyrotopin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75, 738-743.
28. Burnette, R.R. and Ongpipattanakul, B. (1987) Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76, 765-773.
29. Lakshminarayanaiah, N. (1969) Transport Phenomenon in Membranes. Academic Press, New York.
30. Stüttgen, G., Spier, H.W. and Schwarz, G. (1981) Handbuch der Haut-und Geschlechtskrankheiten, Vol. 1/4B. Springer-Verlag, Berlin, pp. 113-147.
31. Rein, H. (1924) Z. Biol. (Munich) 81, 125-140.
32. Pikal, M.J. and Shah, S. (1990b) Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm. Res. 7, 213-221.
33. Pikal, M.J. and Shah, S. (1990c) Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm. Res. 7, 222-229.
34. Siddiqui, O., Roberts, M.S. and Polack, A.E. (1985) The effect of iontophoresis and vehicle pH on the in vitro permeation of lignocaine through human stratum corneum. J. Pharm. Pharmacol. 37, 732-735.
35. Siddiqui, O., Roberts, M.S. and Polack, A.E. (1989) Iontophoretic transport of weak electrolytes through the excised human stratum corneum. J. Pharm. Pharmacol. 41, 430-432.
36. Miller, L.L., Kolaskie, C.J., Smith, G.A. and Rivier, J. (1990) Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogues. J. Pharm. Sci., 79, 490-493.
37. DelTerzo, S., Behl, C.R. and Nash, R.A. (1989) Iontophoretic transport of a homologous series of ionised and nonionised model compounds: influence of hydrophobicity and mechanistic interpretation. Pharm. Res. 6, 85-90.
38. Wearly, L.L. and Chein, Y.W. (1990) Iontophoretic transdermal permeation of verapamil (III): Effect of binding and concentration gradient on reversibility of skin permeation rate. Int. J. Pharm. 59, 87-94.
39. O'Malley, E.P. and Oester, Y.T. (1955) Influence of some physical chemical factors on iontophoresis using radio isotopes. Arch. Phys. Med. Rehabil. 36, 310-316.
40. Abramson, H.A. and Gorin, M.H. (1941) Skin reactions. X. Preseasonal treatment of hay fever by electrophoresis of ragweed pollen extracts into the skin: preliminary report. J. Allergy 12, 169-175.
41. Phipps, J.B. and Gyory, J.R. (1992) Transdermal ion migration. Adv. Drug Deliv. Rev. 9, 137-176.
42. Lelawongs, P., Liu, J.C., Siddiqui, O. and Chien, Y. W. (1989) Transdermal iontophoretic delivery of arginine-vasopressin (I): Physicochemical considerations. Int. J. Pharm. 56, 13-22.
43. Yoshida, N.H. and Roberts, M.S. (1993) Solute molecular size and transdermal iontophoresis across excised human skin. J. Control. Release 9, 239-264.
44. Green, P.G., Hinz, R.S., Cullander, C., Yamane, G. and Guy, R.H. (1991) Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8, 1113-1119.
45. Potts, R.O. and Guy, R.H. (1991) A pore pathway is not necessary to explain skin permeability. Proceedings of the 18th International Symposium on Controlled Release of Bioactive Materials, Amsterdam, p 175.
46. Aveyard, R. and Haydon, D.A. (1973) An Introduction to the principles of surface chemistry. Cambridge University Press, New York, pp. 52-57.
47. Gangarosa, L.P., Merchant, H.W. and Park, N.H. (1979) Iontophoretic application of idoxuridine for recurrent herpes labialis: report of preliminary clinical trials. Methods Find. Exp. Clin. Pharmacol. 1, 105-109.
48. Sims, S.M., Higuchi, W.I. and Srinivasan, V. (1991) Skin alterations and convective solvent flow effects during iontophoresis. I. Neutral solute transport across human skin. Int. J. Pharm. 69, 109-121.
49. Barry, P.H., Diamond, J.M. and Wright, E.M.J. (1971) The mechanism of cation permeation in rabbit gall bladder. Dilution potentials and biionic potentials. J. Membr. Biol. 4, 358-394.
50. Lawler, J.C., Davis, M.J. and Griffith, E. (1960) Electrical characteristics of the skin: The impedance of the surface sheath and deep tissues. J. Invest. Dermatol. 34, 301-308.
51. Bagniefski, T. and Burnette, R.R., (1990) A comparison of pulsed and continuous current iontophoresis. J. Control. Release 11, 113-122.
52. Chien, Y.W., Lelawongs, P., Siddiqui, O., Sun, Y. and Shi, W.M. (1990) Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices. J. Control. Release 13, 263-278.
53. Okabe, K., Yamaguchi, H. and Kawai, Y. (1986) New iontophoretic transdermal administration of the beta-blocker metoprolol. J. Control. Release 4, 79-85.
54. Puttemans, F.J.M., Massart, D.L., Gilles, F., Lievens, P.C. and Jonckeer, M.H. (1982) Iontophoresis: Mechanism of action studied by potentiometry and X-ray fluorescence. Arch. Phys. Med. Rehabil. 63, 176-180.
55. Siddiqui, O. and Chein, Y. W. (1987) Non-parenteral administration of peptide and protein drugs. Crit. Rev. Ther. Drug Carrier Syst. 3, 195-208.
56. Singh, P. and Maibach, H.I. (1994) Iontophoresis in drug delivery: basic principles and applications. Crit. Rev. Ther. Drug Carr. Syst. 11, 161-213.
57. Singh, P., Guy, R.H., Roberts, M.S. and Maibach, H.I. (1994) What is the transport-limiting barrier in iontophoresis? Int. J. Pharm. 101, R1-R5.
58. Singh, P. and Maibach, H.I. (1994) Transdermal iontophoresis: Pharmacokinetic considerations. Clin. Pharmacokinet. 26, 237-244.
59. Riviere, J.E., Sage, B. and Williams, P.L. (1991) Effects of vasoactive drugs on transdermal lidocaine iontophoresis. J. Pharm. Sci. 80, 615-620.
60. Riviere, J.E., Riviere, N.A. and Inman, A.O. (1992) Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharm. Res. 9, 211-214.
61. Shelley, W.B. and Horvath, P.N. (1950) Experimental miliaria in man. III. Production of miliaria rubra (prickly heat). J. Invest. Dermatol. 14, 193-203.
62. Gordon, B.I. and Maibach, H.I. (1969) Eccrine anhydrosis due to glutaraldehyde, formaldehyde and iontophoresis. J. Invest. Dermatol. 53, 436-439.
63. Hill, A.C., Baker, G.F. and Jansen, G.T. (1981) Mechanism of action of iontophoresis in the treatment of palmar hyperhydrosis. Cutis 28, 69-72.
64. Hölzle, E. (1984) Die essentielle Hyperhidrose. Experimentelle Untersuchungen zur Wirkungsweise und zur therapeutischen Anwendung schweisshemmender Massnahmen. Habilitationsschr. Düsseldorf, 166-173.
65. Gibson. L.E. and Cooke, R.E. (1959) A test for the concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23, 545-549.
66. Webster, H.L. (1983) Laboratory diagnosis of cystic fibrosis. Crit. Rev. Clin. Lab. Sci. 18, 313-338.
67. Gibson, L.E., Di Sant' Agnese, P.A. and Shwachman, H. (1975) Procedure for the quantitative iontophoretic sweat test for cystic fibrosis, GAP Conference Reports; Problems in sweat testing. Cystic Fibrosis Foundation, Atlanta.
68. Shapiro, B.L., Pence, T.V. and Warwick, W.J. (1975) Insulin iontophoresis in cystic fibrosis. Proc. Soc. Exp. Biol. Med. 149, 592-593.
69. Bezzant, J.L., Stephen, R.L., Petelenz, T.J. and Jacobsen, S.C. (1988) Painless cauterization of spider veins with the use of iontophoretic local anesthesia. J. Am. Acad. Dermatol. 19, 870-875.
70. Gangarosa, L.P. (1981) Defining a practical solution for iontophoretic local anesthesia. Methods Find. Exp. Clin. Pharmacol. 3, 83-94.
71. Maloney, J.M. (1992) Local anesthesia obtained via iontophoresis as an aid to shave biopsy. Arch. Dermatol. 128, 331-332.
72. Kennard, C.D. and Whitaker, D.C. (1992) Iontophoresis of lidocaine for anesthesia during pulsed dye laser treatment of port-wine stains. J. Dermatol. Surg. Oncol. 18, 287-294.
73. Russo, J., Lipman, A.G., Comstock, T.J., Page, B.C. and Stephen, R.L. (1980) Lidocaine anesthesia: comparison of iontophoresis, injection and swabbing. Am. J. Hosp. Pharm. 37, 843-847.
74. Singh, P. and Roberts, M.S. (1993) Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures. J. Pharm. Sci. 82, 127-131.
75. Arendt-Nielsen, L. and Bjerring, P. (1988) Laser-induced pain for evaluation of topical application (EMLA) and local injection (lidocaine). Anesth. Analg. 67, 115-123.
76. Glass, J.M., Stephen, R.L. and Jacobsen, S.C. (1980) The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis. Int. J. Dermatol. 19, 519-525.
77. Harris, P.R. (1982) Iontophoresis: Clinical research in musculoskeletal inflammatory conditions. J. Orth. Sports Phys. Ther. 4, 109-112.
78. 21 esterified glucocorticoids: preliminary report. J. Am. Phy. Ther. Assoc. 43, 579-581.
79. Chien, Y.W., Siddiqui, O., Shi, W.M., Lelawongs, P. and Liu, J.C. (1989) Direct current iontophoretic transdermal delivery of peptide and protein drugs. J. Pharm. Sci. 78, 377-383.
80. Kumar, S., Char, H., Patel, S., Piemontese, D., Waseem, Malick., Iqbal, K., Malick, A.W., Neugroschel, E. and Behl, C.R. (1992) In vivo transdermal iontophoretic delivery of growth hormone releasing factor GRF (1-44) in hairless guinea pig. J. Control. Release 18, 213-220.
81. Heit, M.C., Williams, P.L., Friederike, L.J., Chang, S.K. and Riviere, J.E. (1993) Transdermal iontophoretic peptide delivery: In vitro and in vivo studies with luteinizing hormone releasing hormone. Pharm. Res. 82, 240-243.
82. Meyer, B.R., Kreis, W., Eschhach, J., O'Mara, V., Rosen, S. and Sibalis D. (1990) Transdermal versus subcutaneous leuprolide: a comparison of acute pharmacodynamic effect. Clin. Pharmacol Ther. 48, 340-345.
83. Kari, B. (1986) Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin. Diabetes 35, 217-221.
84. Meyer, B.R. (1987) Electro-osmotic transdermal drug delivery. In: Proceedings of Conference on the Latest Developments in Drug Delivery Systems. Pharm. Technol. Aster Publ., Springfield, IL. pp. 40-43.
85. Meyer, B.R., Kreis, W., Eschbach, J., O'Mara, V., Rosen, S. and Sibalis, D. (1988) Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin. Pharmacol. Ther. 44, 607-612.
86. Meyer, B.R., Katzeff, H. L. Eschbach, J., Trimmer, J., Zacharias, S.B., Rosen, S. and Sibalis, D., Transdermal delivery of insulin to albino rabbits using electrical current. Am. J. Med. Sci. 297, 321-325.
87. Chien, Y.W., Siddiqui, O., Sun, Y., Shi, W.M. and Liu, J.C. (1989) Transdermal iontophoretic delivery of therapeutic peptides/proteins: (I) Insulin. In: R.L. Juliano (Ed.). Biological approaches to the controlled delivery of drugs, Ann. N.Y. Acad. Sci. 507, 32-51.
88. Green, P.G., Hinz, R.S., Kim, A., Szoka, F.C. and Guy, R.H. (1991) Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm. Res. 8, 1121-1127.
89. Green, P.G., Hinz, R.S., Kim, A., Cullander, C., Yamane, G., Szoka, F.C. and Guy, R.H., Transdermal iontophoresis of amino acids and peptides in vitro. J. Control. Release 21, 187-190.
90. Parasrampuria, D. and Parasrampuria, J. (1991) Percutaneous delivery of protein and peptides using iontophoretic techniques. J. Clin. Pharm. Ther. 16, 7-17.
91. Stephen, R.L., Petelenz, T.J. and Jacobsen, S.C. (1984) Potential novel methods for insulin administration. I. Iontophoresis. Biomed. Biochim. Acta. 43, 553-558.
92. Srinivasan, V., Su, Muh-Hwan, Higuchi, W.I. and Behl, C.R. (1990) Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin. J. Pharm. Sci. 78, 370-375.
93. Pratzel, H., Dittrich, P. and Kukovetz, W. (1986) Spontaneous and forced cutaneous absorption of indomethacin in pigs and humans. J. Rheumatol. 13, 1122-1125.
94. Pratzel, H., Machens, R. and Dittrich, P. (1986) Iontophoresis of forced skin absorption of indomethacin and salicylic acid. Z. Rheumatol. 45, 74-78.
95. Padmanabhan, R.V., Phipps, J.B. and Lattin, G.A. (1986) Transdermal delivery of propranolol via iontophoresis. In: Proceedings of the 13th International Symposium on Controlled Release of Bioactive Materials. Controlled Release Society, Lincolnshire, IL, p. 198.
96. Riviere, J.E., Williams, P.L., Hillman, R.S. and Mishky, L.M. (1992) Quantitative prediction of transdermal iontophoretic delivery of arbutamine in humans with the in vitro isolated perfused porcine skin flap. J. Pharm. Sci. 81, 504-507.
97. Kuo, P.C., Liu, J.C., Chang, S, F. and Chein, Y.W. (1987) Transdermal delivery of oxycodone. I. Animal models, passive diffusion and facilitated transport with iontophoresis. Pharm. Res. 4, S61.
98. Wearly, L.L., Liu, J.C. and Chein, Y.W. (1989) Iontophoresis facilitated transdermal delivery of verapamil. I. in vitro evaluation and mechanistic studies. J. Control. Release 8, 237-250.
99. Hill, J.M., Gangarosa, L.P. and Park, N.H. (1978) Iontophoretic application of antiviral chemotherapeutic agents. Ann. N.Y. Acad. Sci. 284, 604-612.
100. Park, N.H., Gangarosa, L.P. and Hill, J.M. (1977) Iontophoretic application of Ara-AMP (9-β-D-arabinofuranosyladenine-5′-monophosphate) into adult mouse skin. Proc. Soc. Exp. Biol. Med. 156, 326-329.
101. Park, N.H., Gangarosa, L.P., Kwon, B.S. and Hill, J. M. (1977) Iontophoretic application of adenine arabinoside monophosphate to herpes simplex virus type 1-infected hairless mouse skin. Antimicrob. Agents Chemother. 14, 605-608.
102. Kwon, B.S., Hill, J.M. and Wiggins, C. (1979) Iontophoretic application of adenine arabinoside monophosphate for the treatment of herpes simplex virus type 2 skin infections in hairless mice. J. Infect. Dis. 140, 1014.
103. Henley-Conn, J., Hausfeld, J.N. (1984) Iontophoretic treatment of oral herpes. Laryngoscope 94, 118-121.
104. Smith, K.J., Konzelman, J.L., Lombardo, F.A., Skelton, H.G., Holland, T.T., Yeager, J., Wagner, K.F., Oster, C. N. and Chumg, R. (1992) Iontophoresis of vinblastine into normal skin for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. Arch. Dermatol. 128, 1365-1370.
105. Lindbald, L.E., Ekenvall, L., Ancker, K., Rohman, H. and Oberg, P.K. (1986) Laser Doppler flow-meter assessment of iontophoretically applied norepinephrine on human finger skin circulation. J. Invest. Dermatol. 87, 634-636.
106. Tannenbaum, M. (1980) Iodine iontophoresis in reducing scar tissue. Phys. Ther. 60, 792.
107. Cornwall, M.W. (1981) Zinc iontophoresis to treat ischemic skin ulcers. Phys. Ther. 61, 359-360.
108. Gordon, N.H. and Weinstein, M.V. (1969) Sodium salicylate iontophoresis in the treatment of plantar warts. Phys. Ther. 49, 869-870.
109. Moawad, M.B. (1969) Treatment of vitiligo with 1% solution of the sodium salt of mcladine using the iontophoretic technique. Dermatol. Monatsschr. 155, 388-394.
110. Riar, S.S., Sawhney, R.C., Bardhan, J., Thomas, P. and Jain, R.K. (1982) Copper iontophoresis in male contraception. Andrologia 14, 481-491.
111. Jersild, O. and Plesner, N. (1940) Treatment of epidermophytia on the extremities with iontophoresis of copper. Acta Derm. Venereol. (Stockh). 21, 268-279.
112. 21 esterified glucocorticoids. J. Urol. 97, 874-875.
113. Jenkinson, D.M., Mclean, J.A. and Walton, G.S. (1974) The potential use of iontophoresis in the treatment of skin disorders. Vet. Rec. 94, 8-11.
114. Winquist, R.A. and Stamm, S.J. Arterialized capillary sampling using histamine iontophoresis. J. Pediatr. 76, 455-458.
115. Abramson, D.L., Tuck S., Chu, L.S.W. and Busso, E. (1967) Physiologic and clinical basis for histamine by ion transfer. Arch. Phys. Med. Rehabil. 48, 583-591.
116. Magerl, W., Westerman, R.A., Mohner, B. and Handwerker, H.O. (1990) Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region. J. Invest. Dermatol. 94, 347-52.
117. Kahn, J. (1977) Acetic acid iontophoresis for calcium deposits. Phys. Ther. 57, 658-659.
118. Guthrie, T.H., Gangarosa, L.P., Chang, B.K. and Hayakowa, K. (1984) Iontophoretic cisplatin therapy of basal cell carcinoma of the face. Clin. Res. 32, 853A.
119. Shriber, W.J. (1975) A manual of electrotherapy, Lea & Febiger, Philadelphia, pp. 129-134.
120. DeHaan, C.R. and Stark, R.B. (1969) Changes in efferent circulation of tubed pedicles and in the transplantability of large composite grafts produced by histamine iontophoresis. Plast. Reconstr. Surg. 28, 577-583.
121. Kellogg, D.L., Johnson, J.M. and Kosiba, W.A. (1989) Selective abolition of adrenergic vasoconstrictor responses in skin by local iontophoresis of bretylium. Am. J. Physiol. 257, H1599-1606.
122. Wahlberg, J.E. (1970) Skin clearance of iontophoretically administered chromium and sodium ions in the guinea pig. Acta Derm. Venereol. (Stockh). 50, 255-262.
123. Rao, G., Glikfeld, P. and Guy, R.H. (1993) Reverse iontophoresis: development of a noninvasive approach for glucose monitoring. Pharm. Res. 10, 1751-1755.